Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€7.78
17.10.21
-
17.10.22
3.34%
30.10.21

Could be worthwhile Investment >10% per year
4d Pharma plc

Start price
Target price
Perf. (%)
€0.80
17.10.21
€0.60
17.10.22
-15.63%
26.11.21

Could be worthwhile Investment >10% per year
Advicenne

Start price
Target price
Perf. (%)
€7.24
17.10.21
€6.00
17.10.22
-43.92%
18.10.22

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€19.80
17.10.21
€25.00
17.10.22
-15.53%
26.11.21

Could be worthwhile Investment >10% per year
Concert Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.44
17.10.21
-
17.10.22
121.23%
28.05.22

Could be worthwhile Investment >10% per year
Durect Corp.

Start price
Target price
Perf. (%)
€1.03
17.10.21
-
17.10.22
-48.06%
18.10.22

Probably not worthwhile Investment
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€180.85
16.10.21
€160.00
16.10.22
-6.22%
24.10.21

Could be worthwhile Investment >10% per year
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€9.36
16.10.21
€20.00
16.10.22
47.44%
17.10.22

Could be worthwhile Investment >10% per year
buy
Ose Pharma International S.A.

Start price
Target price
Perf. (%)
€9.99
16.10.21
-
16.10.22
-26.78%
04.05.22

Could be worthwhile Investment >10% per year
buy
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€16.58
16.10.21
-
16.10.22
22.56%
24.10.21

Could be worthwhile Investment >10% per year
buy
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.90
16.10.21
-
16.10.22
-
16.10.21

Could be worthwhile Investment >10% per year
buy
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.90
16.10.21
-
16.10.22
-
16.10.21

Could be worthwhile Investment >10% per year
buy
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.90
16.10.21
-
16.10.22
-
16.10.21

Could be worthwhile Investment >10% per year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€23.62
15.10.21
-
18.01.25
-45.89%
24.01.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Cellectis Nom.

Start price
Target price
Perf. (%)
€9.20
15.10.21
€11.50
15.10.22
-61.67%
07.08.22

Could be worthwhile Investment >10% per year
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€7.09
15.10.21
€2.00
15.10.22
-76.35%
15.06.22

Edesa Biotech Inc

Start price
Target price
Perf. (%)
€7.09
15.10.21
-
15.10.22
-86.10%
15.10.22

Edesa Biotech Inc

Start price
Target price
Perf. (%)
€7.09
15.10.21
€3.00
15.10.22
-76.35%
15.06.22

buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€36.37
14.10.21
-
14.10.22
36.29%
15.10.22

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€8.97
13.10.21
-
13.10.22
-12.28%
15.10.21

Could be very worthwhile Investment >20% year
Omeros Corp.

Start price
Target price
Perf. (%)
€6.43
13.10.21
-
13.10.22
3.83%
15.10.21

buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€9.48
13.10.21
-
13.10.22
-1.43%
15.10.21

Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€33.85
13.10.21
€30.00
13.10.22
37.96%
14.10.22

buy
Galapagos N.V.

Start price
Target price
Perf. (%)
€45.08
13.10.21
€46.00
13.10.22
-0.18%
14.10.22

Could be worthwhile Investment >10% per year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€30.25
13.10.21
€34.00
30.07.22
-32.13%
14.03.22

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating